{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:40:30Z","timestamp":1782754830316,"version":"3.54.5"},"reference-count":159,"publisher":"Wiley","issue":"22","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI158649"],"award-info":[{"award-number":["AI158649"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["chemistry-europe.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ChemMedChem"],"published-print":{"date-parts":[[2022,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID\u201019, caused by SARS\u2010CoV\u20102 infection, continues to be a major public health crisis around the globe. Development of vaccines and the first cluster of antiviral drugs has brought promise and hope for prevention and treatment of severe coronavirus disease. However, continued development of newer, safer, and more effective antiviral drugs are critically important to combat COVID\u201019 and counter the looming pathogenic variants. Studies of the coronavirus life cycle revealed several important biochemical targets for drug development. In the present review, we focus on recent drug design and medicinal chemistry efforts in small molecule drug discovery, including the development of nirmatrelvir that targets viral protein synthesis and remdesivir and molnupiravir that target viral RdRp. These are recent FDA approved drugs for the treatment of COVID\u201019.<\/jats:p>","DOI":"10.1002\/cmdc.202200440","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T10:48:57Z","timestamp":1664275737000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS\u2010CoV\u20102 Infection and COVID\u201019"],"prefix":"10.1002","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2472-1841","authenticated-orcid":false,"given":"Arun K.","family":"Ghosh","sequence":"first","affiliation":[{"name":"Department of Chemistry Purdue University  West Lafayette IN 47907 USA"},{"name":"Department of Medicinal Chemistry and Molecular Pharmacology Purdue University  West Lafayette IN 47907 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Mishevich","sequence":"additional","affiliation":[{"name":"Department of Chemistry Purdue University  West Lafayette IN 47907 USA"},{"name":"Department of Medicinal Chemistry and Molecular Pharmacology Purdue University  West Lafayette IN 47907 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mesecar","sequence":"additional","affiliation":[{"name":"Department of Chemistry Purdue University  West Lafayette IN 47907 USA"},{"name":"Department of Biological Sciences Purdue University  West Lafayette IN 47907 USA"},{"name":"Department of Biochemistry Purdue University  West Lafayette IN 47907 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[{"name":"Departments of Hematology and Infectious Diseases Kumamoto University School of Medicine  Kumamoto 860-8556 Japan"},{"name":"Experimental Retrovirology Section HIV and AIDS Malignancy Branch National Cancer Institute  Bethesda MD 20892 USA"},{"name":"National Center for Global Health and Medicine Research Institute  Shinjuku Tokyo 162-8655 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"e_1_2_11_1_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","unstructured":"V. Zoumpourlis M. Goulielmaki E. Rizos S. Baliou D. Spandidos [Comment] The COVID-19 Pandemic as a Scientific and Social Challenge in the 21st Century.Mol. Med.2020.","DOI":"10.3892\/mmr.2020.11393"},{"key":"e_1_2_11_4_1","unstructured":"WHO-convened global study of origins of SARS-CoV-2: China Part.https:\/\/www.who.int\/publications-detail-redirect\/who-convened-global-study-of-origins-of-sars-cov-2-china-part."},{"key":"e_1_2_11_5_1","unstructured":"Coronavirus COVID-19 (2019-nCoV).https:\/\/gisanddata.maps.arcgis.com\/apps\/dashboards\/bda7594740fd40299423467b48e9ecf6."},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.4014\/jmb.2110.10029"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092723"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000223"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2014.12.015"},{"key":"e_1_2_11_11_1","unstructured":"\u00a0"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0118-9"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60454-8"},{"key":"e_1_2_11_14_1","unstructured":"\u00a0"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab456"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2040341"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1143"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.5.2.245"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030747"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/420743"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.08.015"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-359"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/522139a"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","unstructured":"J.\u2005S. Morse T. Lalonde S. Xu W. Liu Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-NCoV; preprint; Chemistry 2020.","DOI":"10.26434\/chemrxiv.11728983.v1"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.11.038"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-4-853"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg916"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chempr.2020.04.023"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01461"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.09.001"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2007.02.017"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.12.009"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19424-0"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1835675100"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510851103"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01294-14"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105969"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13895"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104541"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00489"},{"key":"e_1_2_11_42_1","doi-asserted-by":"crossref","unstructured":"Remdesivir for the Treatment of Covid-19 \u2013 Preliminary Report.N. Engl. J. Med.2020 383 992\u2013994.","DOI":"10.1056\/NEJMc2022236"},{"key":"e_1_2_11_43_1","first-page":"e01117","volume":"65","author":"Yan V. C.","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_2_11_44_1","unstructured":"WHO recommends against the use of remdesivir in COVID-19 patients.https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients."},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116846"},{"key":"e_1_2_11_46_1","doi-asserted-by":"crossref","unstructured":"P.-V. Ennezat Outpatient Remdesivir to Prevent Progression to Severe Covid-19.N. Engl. J. Med.2022 386 1094\u20131094.","DOI":"10.1056\/NEJMc2200591"},{"key":"e_1_2_11_47_1","doi-asserted-by":"crossref","unstructured":"W. Fischer J.\u2005J. Eron W. Holman M.\u2005S. Cohen L. Fang L.\u2005J. Szewczyk T.\u2005P. Sheahan R. Baric K.\u2005R. Mollan C.\u2005R. Wolfe E.\u2005R. Duke M.\u2005M. Azizad K. Borroto-Esoda D.\u2005A. Wohl A.\u2005J. Loftis P. Alabanza F. Lipansky W.\u2005P. Painter Molnupiravir an Oral Antiviral Treatment for COVID-19; preprint; Infectious Diseases (except HIV\/AIDS) 2021.","DOI":"10.1101\/2021.06.17.21258639"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116044"},{"key":"e_1_2_11_49_1","unstructured":"Commissioner O. of the.Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. FDA.https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain."},{"key":"e_1_2_11_50_1","unstructured":"EUA 105 Pfizer Paxlovid LOA."},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4784"},{"key":"e_1_2_11_52_1","doi-asserted-by":"crossref","unstructured":"A.\u2005K. Ghosh K. Xi M.\u2005E. Johnson S.\u2005C. Baker A.\u2005D. Mesecar Progress in Anti-SARS Coronavirus Chemistry Biology and Chemotherapy.Annual Reports in Medicinal Chemistry; Elsevier 2006; Vol. 41 pp 183\u2013196.","DOI":"10.1016\/S0065-7743(06)41011-3"},{"key":"e_1_2_11_53_1","unstructured":"Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89\u2009% in Interim Analysis of Phase 2\/3 EPIC-HR Study | Pfizer.https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizers-novel-covid-19-oral-antiviral-treatment-candidate."},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206776361110"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000688"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.32607\/20758251-2016-8-4-23-32"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X17729626"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2020.12.030"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01577-x"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1021\/acscatal.0c00110"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010259"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm050548m"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.08.031"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0494873"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20900-6"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01348-12"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03688-14"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113584"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18233-x"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.852210"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0356-z"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm060173k"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.3.1013-1020.2006"},{"key":"e_1_2_11_74_1","unstructured":"\u00a0"},{"key":"e_1_2_11_75_2","unstructured":"B.\u2005J. Anson M.\u2005E. Chapman E.\u2005K. Lendy S. Pshenychnyi R.\u2005T. D\u2032Auila K.\u2005J.\u2005F. Satchell A.\u2005D. Mesecar. Broad-Spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs.Res. Square PREPRINT https:\/\/doi.org.10.21203\/rs.3.rs-26344\/v1;"},{"key":"e_1_2_11_76_2","doi-asserted-by":"publisher","DOI":"10.1039\/D0MD00367K"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf1611"},{"key":"e_1_2_11_78_1","unstructured":"\u00a0"},{"key":"e_1_2_11_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114570"},{"key":"e_1_2_11_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114596"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01119-7"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00099"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00616"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00233a007"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja00221a062"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(97)00102-7"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/15376516.2017.1373882"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01063"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29915-z"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00883-2"},{"key":"e_1_2_11_91_1","unstructured":"Pfizer unveils its oral SARS-CoV-2 inhibitor. Chemical & Engineering News.https:\/\/cen.acs.org\/acs-news\/acs-meeting-news\/Pfizer-unveils-oral-SARS-CoV\/99\/i13."},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2697"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-022-00618-w"},{"key":"e_1_2_11_95_1","unstructured":"EPIC-Peds: Study of Oral PF-07321332 (Nirmatrelvir)\/Ritonavir in Nonhospitalized COVID-19 Pediatric Patients at Risk for Severe Disease - Full Text View - ClinicalTrials.gov.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05261139."},{"key":"e_1_2_11_96_1","unstructured":"D.\u2005K.\u2005D. Rai I. Yurgelonis P. McMonagle H.\u2005A. Rothan L. Hao A. Gribenko E. Titova B. Kreiswirth K.\u2005M. White Y. Zhu A.\u2005S. Anderson R.\u2005D. Cardin.Nirmatrelvir an Orally Active Mpro Inhibitor Is a Potent Inhibitor of SARS-CoV-2 Variants of Concern; preprint; Microbiology 2022."},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01214"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195782"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00636"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202016961"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23751-3"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00299"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301580n"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00509"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.1c08060"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.1c00039"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00598"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00117"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00624"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2601-5"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004113"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17050678"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805240105"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm900611t"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21060-3"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20718-8"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.08.014"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01307"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2021.04.020"},{"key":"e_1_2_11_121_1","doi-asserted-by":"crossref","unstructured":"B. Wang V. Svetlov Y.\u2005I. Wolf E.\u2005V. Koonin E. Nudler I. Artsimovitch. Allosteric Activation of SARS-CoV-2 RNA-Dependent RNA Polymerase by Remdesivir Triphosphate and Other Phosphorylated Nucleotides.mBio2021 12 e0142321.","DOI":"10.1128\/mBio.01423-21"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-021-00651-0"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.26452\/ijrps.v12i3.4798"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab278"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20542-0"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.3390\/cryst11050471"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16349"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007016"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26760-4"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105078"},{"key":"e_1_2_11_132_1","unstructured":"Stanford University.A Phase 2 Randomized Double Blinded Placebo Controlled Study of Oral Favipiravir Compared to Standard Supportive Care in Subjects With Mild or Asymptomatic COVID-19; Clinical trial registration NCT04346628; clinicaltrials.gov 2021."},{"key":"e_1_2_11_133_1","unstructured":"Fujifilm Pharmaceuticals U.\u2005S.\u2005A. Inc.Open Label Randomized Controlled Phase 2 Proof-of-Concept Study of the Use of Favipiravir Compared to Standard of Care in Hospitalized Subjects With COVID-19; Clinical trial registration NCT04358549; clinicaltrials.gov 2021."},{"key":"e_1_2_11_134_1","unstructured":"Appili Therapeutics Inc.Favipiravir for Patients With Mild to Moderate Disease From Novel Coronavirus (COVID-19); Clinical trial registration NCT04600895; clinicaltrials.gov 2021."},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18463-z"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021946118"},{"key":"e_1_2_11_137_1","unstructured":"Merck Sharp & Dohme Corp.A Phase 2\/3 Randomized Placebo-Controlled Double-Blind Clinical Study to Evaluate the Efficacy Safety and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults With COVID-19.; Clinical trial registration NCT04575597; clinicaltrials.gov 2021."},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195795"},{"key":"e_1_2_11_139_1","first-page":"103595","volume":"72","author":"Abdelnabi R.","year":"2021","journal-title":"e-biomed"},{"key":"e_1_2_11_140_1","first-page":"1","author":"Elfiky A. A.","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.02.011"},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050893"},{"key":"e_1_2_11_143_1","doi-asserted-by":"crossref","unstructured":"K. Zandi F. Amblard K. Musall J. Downs-Bowen R. Kleinbard A. Oo. D. Cao B. Liang O.\u2005O. Russell T. McBrayer L. Bassit B. Kim R.\u2005F. Schinazi. Repurposing Nucleoside Analogs for Human Coronaviruses.Antimicrob. Agents Chemother.2020 65 e01652\u201320.","DOI":"10.1128\/AAC.01652-20"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17495-9"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abe1202"},{"key":"e_1_2_11_146_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00131"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00140"},{"key":"e_1_2_11_148_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c00120"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00542-x"},{"key":"e_1_2_11_150_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00263"},{"key":"e_1_2_11_151_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00070"},{"key":"e_1_2_11_152_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.1c00023"},{"key":"e_1_2_11_153_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.1c00263"},{"key":"e_1_2_11_154_1","unstructured":"Kinase Inhibitors. COVID-19 Treatment Guidelines.https:\/\/www.covid19treatmentguidelines.nih.gov\/therapies\/immunomodulators\/kinase-inhibitors\/."},{"key":"e_1_2_11_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108393"},{"key":"e_1_2_11_156_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220049"},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30304-4"},{"key":"e_1_2_11_158_1","unstructured":"Research C. for D.\u2005E. and.Coronavirus (COVID-19) | Drugs. FDA.https:\/\/www.fda.gov\/drugs\/emergency-preparedness-drugs\/coronavirus-covid-19-drugs."},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031994"}],"container-title":["ChemMedChem"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cmdc.202200440","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cmdc.202200440","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cmdc.202200440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:46:51Z","timestamp":1760276811000},"score":1,"resource":{"primary":{"URL":"https:\/\/chemistry-europe.onlinelibrary.wiley.com\/doi\/10.1002\/cmdc.202200440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":159,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,11,18]]}},"alternative-id":["10.1002\/cmdc.202200440"],"URL":"https:\/\/doi.org\/10.1002\/cmdc.202200440","archive":["Portico"],"relation":{},"ISSN":["1860-7179","1860-7187"],"issn-type":[{"value":"1860-7179","type":"print"},{"value":"1860-7187","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"2022-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e202200440"}}